Patents by Inventor Olga SLACK

Olga SLACK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20220241398
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 4, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: KATHRYN HASHEY, PADMA MALYALA, MARCELO SAMSA, OLGA SLACK, DONG YU, ALAN STOKES, RASHMI JALAH
  • Lyssavirus antigen constructs
    Patent number: 11278613
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: March 22, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn Hashey, Padma Malyala, Marcelo Samsa, Olga Slack, Dong Yu, Alan Stokes, Rashmi Jalah
  • SYNTHETIC RNAS AND METHODS OF USE
    Publication number: 20210180053
    Abstract: A manufacturing process of RNA having a length of about 20-200 bases with improved performance, by using in vitro transcription in combination with other methodologies that may increase yield and quality.
    Type: Application
    Filed: October 31, 2018
    Publication date: June 17, 2021
    Inventors: Michael BEVERLY, Caitlin Jeanette HAGEN, Olga SLACK, Jan WEILER
  • POLYA TAIL LENGTH ANALYSIS OF RNA BY MASS SPECTROMETRY
    Publication number: 20200325532
    Abstract: Described herein are methods of analyzing and producing RNA compositions, e.g., mRNA compositions, that include determining the amount of a polyA chain length and/or 5 the relative distribution of polyA chain lengths in a sample from the RNA composition using mass spectrometry, e.g., LC-MS or MALDI-MS.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 15, 2020
    Inventors: Michael BEVERLY, Caitlin Jeanette HAGEN, Olga SLACK
  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20200222526
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: July 16, 2018
    Publication date: July 16, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn HASHEY, Padma MALYALA, Marcelo SAMSA, Olga SLACK, Dong YU, Alan STOKES, Rashmi JALAH